Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 4/20 | 0.41 |
| ▸ | HTR2A | P28223 | 1/20 | 0.41 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.38 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.38 |
| ▸ | SCN4A | P35499 | 2/20 | 0.36 |
| ▸ | LTA4H | P09960 | 2/20 | 0.36 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.36 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.36 |
| ▸ | DPP4 | P27487 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | KCNA3 | P22001 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11802140 | 0.79 | MTNR1A (0.39) | TAAR1MTNR1AMTNR1BSCN4ALTA4H | |
| SCHEMBL28057724 | 0.77 | MTNR1A (0.38) | MTNR1AMTNR1BLTA4HTSHRKCNA3 | |
| SCHEMBL8108204 | 0.77 | MTNR1A (0.42) | MTNR1AMTNR1BLTA4HTSHRKCNA3 | |
| SCHEMBL11515377 | 0.76 | TAAR1 (0.44) | TAAR1HTR2ASCN4ALTA4HPLA2G2A | |
| SCHEMBL7305170 | 0.76 | TAAR1 (0.44) | TAAR1HTR2ASCN4ALTA4HPLA2G2A | |
| SCHEMBL15349936 | 0.76 | LMNA (0.50) | TAAR1MTNR1AMTNR1BSCN4AKCNA3 | |
| SCHEMBL10372698 | 0.74 | SLC6A4 (0.41) | MTNR1AMTNR1BLTA4H | |
| SCHEMBL11072413 | 0.73 | TSHR (0.41) | TAAR1SCN4ALTA4HDPP4TSHR | |
| SCHEMBL17459935 | 0.73 | TAAR1 (0.41) | TAAR1HTR2ASCN4ALTA4HPLA2G2A | |
| SCHEMBL3160069 | 0.73 | MTNR1A (0.50) | TAAR1HTR2AMTNR1AMTNR1BLTA4H |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030055066-A1 | Phenoxypropanol connected with phenylpiperazine and phenoxyalkylamine terminal in its side chain | LIN, TONG-HO (TW) | 2003-03-20 | — | — | US | claimed |
| US-6846826-B2 | Phenoxypropanol connected with phenylpiperazine and phenoxyalkylamine terminal in its side chain | Chen, Ing-Jun (TW) | 2005-01-25 | — | — | US | disclosed |
| US-20030055066-A1 | Phenoxypropanol connected with phenylpiperazine and phenoxyalkylamine terminal in its side chain | LIN, TONG-HO (TW) | 2003-03-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030055066-A1 | Phenoxypropanol connected with phenylpiperazine and phenoxyalkylamine terminal in its side chain | KCNH2, ADRB3, KCNH3 | TAAR1 506/4885HTR2A 365/4885MTNR1A 833/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.